Breathe BioMedical Inc. (BRTH)

Breathe BioMedical will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Breathe BioMedical Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-8.36	-4.46	-3.97
Depreciation & Amortization	0.47	0.26	0.22
Share-Based Compensation	2.27	0.62	0.71
Other Operating Activities	0.54	0.66	0.29
Operating Cash Flow	-5.09	-2.93	-2.75
Change in Investments	-	-	1.78
Other Investing Activities	-0.13	-0.6	-0.75
Investing Cash Flow	-0.13	-0.6	1.02
Dividends Paid	-0.13	-0.6	-0.75
Share Issuance / Repurchase	5.43	2.76	1.71
Debt Issued / Paid	0.88	0.62	0.01
Other Financing Activities	0.13	0.6	0.75
Financing Cash Flow	6.31	3.38	1.72
Net Cash Flow	1.09	-0.15	-0.01
Free Cash Flow	-5.22	-3.53	-3.5

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).